Digital musculoskeletal care company Hinge Health and virtual care specialist Midi Health are teaming up to combine Hinge’s movement-based support with Midi’s virtual care clinic to support women experiencing menopausal symptoms.
California-based Midi Health offers a network of nurse practitioners overseen by physicians and researchers to women 40 years and above going through perimenopause and menopause. It also provides interventions from lifestyle coaching to prescription medication.
Hinge Health provides individuals with musculoskeletal conditions access to health coaches, orthopedic surgeons, physical therapists and technological resources, such as surgery decision support.
The partners will provide a holistic approach to help women manage menopause and address musculoskeletal symptoms that many women face during menopause, such as joint and muscle pain.
Hinge members who are in-network with Midi will gain access to personalized menopause treatment plans, including consultations with prescribing clinicians specializing in menopause.
Hinge will also direct members to Midi’s resources, which offer a spectrum of menopause care options.
A recent review from the University of Central Florida School of Medicine underscores the need for increased awareness and treatment of these symptoms, introducing the term “musculoskeletal syndrome of menopause” to highlight their significance.
“Having experienced Midi Health firsthand as a patient, I’m proud to bring their outstanding virtual care to our Hinge Health members,” Arielle Slam, principal product manager for women’s health at Hinge Health, told MobiHealthNews.
Slam said that by combining Hinge’s advanced musculoskeletal care and movement therapy with Midi’s national network of menopause specialists, women can receive comprehensive menopause care anywhere without delay.
Midi CEO and cofounder Joanna Strober told MobiHealthNews that the partnership with Hinge would extend the scope of treatment they provide to patients going through menopause and experiencing midlife joint, muscular or pelvic pain.
“We share a belief in providing holistic and personalized care according to a woman’s specific needs, whether that be movement-based therapies from Hinge or prescription and/or hormone therapy through Midi clinicians or all of these,” Strober said.
THE LARGER TREND
Midi Health secured $60 million in a Series B funding round in April, bringing its total raise to $100 million. The company scored $25 million in a Series A round led by GV (Google Ventures) less than a year before and $14 million in seed investment in 2022.
Last year, the company announced a partnership with Houston-based Memorial Hermann Health System to provide the health system’s patients with access to Midi Health’s services by going directly to the company’s website or through a referral by a Hermann Health provider.
In March, the California-based company teamed up with Neurotrack, a digital cognitive assessment company, to help women determine whether brain fog symptoms are indicative of menopause or signs of severe cognitive impairment such as early dementia.
Hinge, founded in 2015, partnered with employee and government benefits organization Sun Life in July to offer Sun Life members access to its musculoskeletal offerings, including its clinicians, programs and resources, and its FDA-cleared wearable device Enso that helps manage pain.
Last year, Hinge launched a physical therapy house call service, which started in Chicago, designed to complement its digital care offerings, and in 2022, it launched a women’s pelvic health program.
Other players in the digital musculoskeletal care and physical therapy space include Sword Health, which offers a female pelvic pain product called Bloom, and Renovia, which markets a digital therapeutic to treat urinary incontinence by strengthening the pelvic floor.
